denver developmental screening test ii pdf converter

The developmental screening tools used in the NHSPIC should be able to comprehensively assess the developmental domains to sensitively identify children at risk of suffering from neurodevelopmental disorders. Among these, the developmental evaluation is the major screening item of NHSPIC, with the first 9–12 months, the second in 18–24 months, the third in 30–36 months, the fourth in 42–48 months, the fifth in 54–60 months, and the sixth in 66–71 months of age, all but 4–6 months, the first NHSPIC period. NHSPIC is conducted for the first to seventh rounds as protocols divided by the scope of questionnaire and physical examination, physical measurements, development evaluation and consultation, health education, and oral examination. National Health Screening Program for Infants and Children (NHSPIC) has been rolled out nationwide since November 2007 to keep track of the growth and development of infants and children and to provide proper education programs to caregivers, with the introduction of a health check-up program suitable for the age of infants and children. Therefore, if early screening of infants and children who may have future developmental problems is possible through assessment, then a more accurate assessment should be conducted to plan for appropriate treatments and rehabilitation. The most common clinical symptom of neurodevelopmental disorders is the lack of developmental skills consistent with their age. Particularly, infants and children are the most important periods for development, and developmental evaluation during this period may reduce the chances of future disorders and prevent secondary sequelae. The assessment of growth and development is essential for growing children. The Verbal Intelligence Quotient of Korean Wechsler Preschool and Primary Scales of Intelligence was highly correlated with the K-DST cognition and language domains (r=0.701, 0.770), as was the performance intelligence quotient with the fine motor domain (r=0.700).ConclusionThe K-DST is reliable and valid, suggesting its good potential as an effective screening tool for infants and children with neurodevelopmental disorders in Korea. The language and cognition domain of the revised K-DST was highly correlated with the K-Bayley Scales of Infant Development-II's Mental Age Quotient (r=0.766, 0.739), while the gross and fine motor domains were highly correlated with Motor Age Quotient (r=0.695, 0.668), respectively.

The test supported construct validity by distinguishing between normal and neurodevelopmentally delayed groups.

The revised K-DST had high discriminatory ability with a sensitivity of 0.833 and specificity of 0.979. For most age groups and each domain, internal consistency was 0.73-0.93 and test-retest reliability was 0.77-0.88. Regarding the validation of K-DST, we examined the construct validity, sensitivity and specificity, receiver operating characteristic curve analysis, and a criterion-related validity analysis.ResultsWe ultimately selected 8 questions in 6 developmental domains. We analyzed inter-item consistency and test-retest reliability for the reliability analysis. The restandardization and revalidation performed in 2015-2016 of 3.06 million attendees of the National Health Screening Program for Infants and Children resulted in the revised K-DST. To ensure efficient screening of infants and children in Korea, a nationwide screening tool with high reliability and validity is needed.PurposeThis study aimed to independently develop, standardize, and validate the Korean Developmental Screening Test for Infants and Children (K-DST) for screening infants and children for neurodevelopmental disorders in Korea.MethodsThe standardization and validation conducted in 2012-2014 of 3,284 subjects (4-71 months of age) resulted in the first edition of the K-DST. BackgroundMost developmental screening tools in Korea are adopted from foreign tests.

Denver developmental screening test ii pdf converter